density heatmaps plot using combination of python libraries like plotly and pandas Search Results


86
Plotly Technologies Inc gene expression heatmaps
Gene Expression Heatmaps, supplied by Plotly Technologies Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/density+heatmaps+plot+using+combination+of+python+libraries+like+plotly+and+pandas/pm42099015-273-7-1?v=Plotly+Technologies+Inc
Average 86 stars, based on 1 article reviews
gene expression heatmaps - by Bioz Stars, 2026-07
86/100 stars
  Buy from Supplier

86
Plotly Technologies Inc heatmap
( A ) <t>Heatmap</t> of LC/MS-analyzed 122 polar metabolites from double thymidine block (DTB)-synchronized HeLa cells. Analytes are clustered and colored by metabolic pathway. Carbamoyl-aspartate, dihydroorotate, and orotate are highlighted in purple. The presented result is in logarithmic ratio (log2 fold change relative to DTB) of the mean of biological triplicate (n = 3, biological replicates). ( B ) De novo pyrimidine biosynthesis pathway. Carbons are depicted in a circle; nitrogens, square; ribose, pentagon; phosphate groups, a P in a circle; Amide- 15 N of glutamine, red. ( C ) Relative changes of intracellular amide- 15 N glutamine-derived 15 N-dihydroorotate concentration after DTB release (left) or post-nocodazole (NOC) release (right). 1 hour amide- 15 N glutamine labeling. 15 N-labeled dihydroorotate, pink, unlabeled dihydroorotate, black. Data are presented as mean (n = 3, biological replicates) +/− SD (standard deviation). Two-tailed Student t-test statistical analyses applied. ( D ) Genomic incorporation of EdU. Uridine (100 μg/mL) PALA (300 μM, 24 h) as indicated. ( E ) Relative intracellular dihydroorotate concentration in wild-type HeLa, sgCAD, and wild-type CAD-reconstituted sgCAD cells. Data are presented as mean +/− SD (n = 3, biological replicates). Two-tailed Student t-test statistical analyses applied. Two-tailed Student’s t-test statistical analyses applied. ( F ) Cell proliferation of sgCAD cells upon supplementation of 500 μM of indicated molecules. 4 days of supplementation duration. Data are presented as mean +/− SD (n = 3, technical replicates, 3 independent experiments). Two-tailed Student’s t-test statistical analyses applied. ( G ) Cell proliferation of wild-type HeLa, sgCAD, and wild-type CAD-reconstituted sgCAD cells upon uridine supplementation, as indicated. Data are presented as mean +/− SD (n = 3, technical replicates, 2 independent experiments). Two-tailed Student’s t-test statistical analyses applied. Compared to the cells with 0 μg/mL. ( H ) Immunoblotting of lysates from sgCAD at indicated time after uridine withdrawal or uridine supplementation (100 μg/mL). P-values denoted as * (* for p-value < 0.1; **, < 0.01; ***, < 0.001; ****, < 0.0001) or ns (not significant).
Heatmap, supplied by Plotly Technologies Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/density+heatmaps+plot+using+combination+of+python+libraries+like+plotly+and+pandas/pmc10064490-618-6-7?v=Plotly+Technologies+Inc
Average 86 stars, based on 1 article reviews
heatmap - by Bioz Stars, 2026-07
86/100 stars
  Buy from Supplier

Image Search Results


( A ) Heatmap of LC/MS-analyzed 122 polar metabolites from double thymidine block (DTB)-synchronized HeLa cells. Analytes are clustered and colored by metabolic pathway. Carbamoyl-aspartate, dihydroorotate, and orotate are highlighted in purple. The presented result is in logarithmic ratio (log2 fold change relative to DTB) of the mean of biological triplicate (n = 3, biological replicates). ( B ) De novo pyrimidine biosynthesis pathway. Carbons are depicted in a circle; nitrogens, square; ribose, pentagon; phosphate groups, a P in a circle; Amide- 15 N of glutamine, red. ( C ) Relative changes of intracellular amide- 15 N glutamine-derived 15 N-dihydroorotate concentration after DTB release (left) or post-nocodazole (NOC) release (right). 1 hour amide- 15 N glutamine labeling. 15 N-labeled dihydroorotate, pink, unlabeled dihydroorotate, black. Data are presented as mean (n = 3, biological replicates) +/− SD (standard deviation). Two-tailed Student t-test statistical analyses applied. ( D ) Genomic incorporation of EdU. Uridine (100 μg/mL) PALA (300 μM, 24 h) as indicated. ( E ) Relative intracellular dihydroorotate concentration in wild-type HeLa, sgCAD, and wild-type CAD-reconstituted sgCAD cells. Data are presented as mean +/− SD (n = 3, biological replicates). Two-tailed Student t-test statistical analyses applied. Two-tailed Student’s t-test statistical analyses applied. ( F ) Cell proliferation of sgCAD cells upon supplementation of 500 μM of indicated molecules. 4 days of supplementation duration. Data are presented as mean +/− SD (n = 3, technical replicates, 3 independent experiments). Two-tailed Student’s t-test statistical analyses applied. ( G ) Cell proliferation of wild-type HeLa, sgCAD, and wild-type CAD-reconstituted sgCAD cells upon uridine supplementation, as indicated. Data are presented as mean +/− SD (n = 3, technical replicates, 2 independent experiments). Two-tailed Student’s t-test statistical analyses applied. Compared to the cells with 0 μg/mL. ( H ) Immunoblotting of lysates from sgCAD at indicated time after uridine withdrawal or uridine supplementation (100 μg/mL). P-values denoted as * (* for p-value < 0.1; **, < 0.01; ***, < 0.001; ****, < 0.0001) or ns (not significant).

Journal: Nature metabolism

Article Title: Allosteric regulation of CAD modulates de novo pyrimidine synthesis during the cell cycle

doi: 10.1038/s42255-023-00735-9

Figure Lengend Snippet: ( A ) Heatmap of LC/MS-analyzed 122 polar metabolites from double thymidine block (DTB)-synchronized HeLa cells. Analytes are clustered and colored by metabolic pathway. Carbamoyl-aspartate, dihydroorotate, and orotate are highlighted in purple. The presented result is in logarithmic ratio (log2 fold change relative to DTB) of the mean of biological triplicate (n = 3, biological replicates). ( B ) De novo pyrimidine biosynthesis pathway. Carbons are depicted in a circle; nitrogens, square; ribose, pentagon; phosphate groups, a P in a circle; Amide- 15 N of glutamine, red. ( C ) Relative changes of intracellular amide- 15 N glutamine-derived 15 N-dihydroorotate concentration after DTB release (left) or post-nocodazole (NOC) release (right). 1 hour amide- 15 N glutamine labeling. 15 N-labeled dihydroorotate, pink, unlabeled dihydroorotate, black. Data are presented as mean (n = 3, biological replicates) +/− SD (standard deviation). Two-tailed Student t-test statistical analyses applied. ( D ) Genomic incorporation of EdU. Uridine (100 μg/mL) PALA (300 μM, 24 h) as indicated. ( E ) Relative intracellular dihydroorotate concentration in wild-type HeLa, sgCAD, and wild-type CAD-reconstituted sgCAD cells. Data are presented as mean +/− SD (n = 3, biological replicates). Two-tailed Student t-test statistical analyses applied. Two-tailed Student’s t-test statistical analyses applied. ( F ) Cell proliferation of sgCAD cells upon supplementation of 500 μM of indicated molecules. 4 days of supplementation duration. Data are presented as mean +/− SD (n = 3, technical replicates, 3 independent experiments). Two-tailed Student’s t-test statistical analyses applied. ( G ) Cell proliferation of wild-type HeLa, sgCAD, and wild-type CAD-reconstituted sgCAD cells upon uridine supplementation, as indicated. Data are presented as mean +/− SD (n = 3, technical replicates, 2 independent experiments). Two-tailed Student’s t-test statistical analyses applied. Compared to the cells with 0 μg/mL. ( H ) Immunoblotting of lysates from sgCAD at indicated time after uridine withdrawal or uridine supplementation (100 μg/mL). P-values denoted as * (* for p-value < 0.1; **, < 0.01; ***, < 0.001; ****, < 0.0001) or ns (not significant).

Article Snippet: The dendrogram was paired with a heatmap (plotly.graph_objects) of log 2 fold change of metabolites.

Techniques: Activity Assay, Liquid Chromatography with Mass Spectroscopy, Blocking Assay, Derivative Assay, Concentration Assay, Labeling, Standard Deviation, Two Tailed Test, Western Blot